Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Testori

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
Dermatology (Basel, Switzerland)|June 6, 2013
Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanomaVanna Chiarion-Sileni, Michele Guida, Antonella Romanini, et al.
Melanoma Research|March 11, 2010
Radio-guided ultrasound lymph node localization: feasibility of a new technique for localizing and excising nonpalpable lymph nodes ultrasound suspicious for melanoma metastasesAlessandro Testori, Marco Rastrelli, Elvio De Fiori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanomaMichele Maio, Andrzej Mackiewicz, Alessandro Testori, et al.
Anticancer Research|December 13, 2005
Computer-aided diagnosis of melanocytic lesionsIgnazio Stanganelli, Aldo Brucale, Luigi Calori, et al.
World Journal of Surgical Oncology|September 12, 2012
Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitationsEmilio Bertani, Alessandro Testori, Antonio Chiappa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trialMichele Maio, Jean-Jacques Grob, Steinar Aamdal, et al.
Journal of Surgical Oncology|April 12, 2011
Diagnostic and therapeutic imaging for cancer: therapeutic considerations and future directionsMack Roach, Jean-Louis Alberini, Alain Paul Pecking, et al.
Blood|September 15, 2010
Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-upRichard K Burt, Robert M Craig, Francesca Milanetti, et al.
Journal of Translational Medicine|April 18, 2020
The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019Paolo A Ascierto, Sanjiv S Agarwala, Alexander Eggermont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study GroupAlessandro Testori, Jon Richards, Eric Whitman, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
Dermatology (Basel, Switzerland)|June 6, 2013
Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanomaVanna Chiarion-Sileni, Michele Guida, Antonella Romanini, et al.
Melanoma Research|March 11, 2010
Radio-guided ultrasound lymph node localization: feasibility of a new technique for localizing and excising nonpalpable lymph nodes ultrasound suspicious for melanoma metastasesAlessandro Testori, Marco Rastrelli, Elvio De Fiori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanomaMichele Maio, Andrzej Mackiewicz, Alessandro Testori, et al.
Anticancer Research|December 13, 2005
Computer-aided diagnosis of melanocytic lesionsIgnazio Stanganelli, Aldo Brucale, Luigi Calori, et al.
World Journal of Surgical Oncology|September 12, 2012
Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitationsEmilio Bertani, Alessandro Testori, Antonio Chiappa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trialMichele Maio, Jean-Jacques Grob, Steinar Aamdal, et al.
Journal of Surgical Oncology|April 12, 2011
Diagnostic and therapeutic imaging for cancer: therapeutic considerations and future directionsMack Roach, Jean-Louis Alberini, Alain Paul Pecking, et al.
Blood|September 15, 2010
Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-upRichard K Burt, Robert M Craig, Francesca Milanetti, et al.
Journal of Translational Medicine|April 18, 2020
The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019Paolo A Ascierto, Sanjiv S Agarwala, Alexander Eggermont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study GroupAlessandro Testori, Jon Richards, Eric Whitman, et al.
Pageof 16